资讯
Columnist Dagmar Munn shares how she finds ways to keep her anxiety and ALS fears in check with a few simple responses.
Klotho is advancing its ALS gene therapy candidate KLTO‑202 to the manufacturing phase, and is planning the first human ...
KLTO-202 designed to slow disease progression KLTO-202 is designed to boost the production of that protein in muscle and nerve cells by delivering the gene that codes for s-KL via a modified and ...
The FDA granted orphan drug designation to Sineugene Therapeutics' SNUG01, a first-in-class experimental gene therapy for ...
As her husband's ALS journey extends, columnist Kristin Neva considers finally "settling in," so to speak, by securing a better bed.
Clene is continuing to work with U.S. regulators on its plans to seek accelerated approval of CNM-Au8 for the treatment of ...
A Q&A with author and activist Mindy Uhrlaub, who shares how she is using her voice to raise awareness and support for the ...
The Longitude Prize on ALS is offering £7.5 million to encourage scientists to use AI to speed up the search for new treatments.
Living near water bodies with toxic blue-green algal blooms is linked to significantly reduced survival among people with ALS, per a study.
Columnist Juliet Taylor used to face difficulties with stoicism, but her late husband's ALS diagnosis forced to her feel her ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果